NCM · Price History

Barinthus Biotherapeutics plc (BRNS) Price History & Returns

$0.67 NCM: BRNS

How Barinthus Biotherapeutics plc (BRNS) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $0.67 sits 7% of the way up a 52-week range of $0.51 to $2.91; 77.0% below the 52-week high; a beta of -0.40 means it has historically moved opposite the market.

Total return

Price change over each trailing period, not annualised.

Period	Return
3 months	+13.6%
6 months	-7.6%
1 year	-52.8%
3 years	-70.3%
5 years	+0.0%
10 years	+0.0%

Barinthus Biotherapeutics plc (BRNS) price history — frequently asked questions

How has Barinthus Biotherapeutics plc performed over the last year?

Barinthus Biotherapeutics plc (BRNS) has fallen 52.8% over the last twelve months, measured on price alone.

What is Barinthus Biotherapeutics plc's five-year return?

Over five years the BRNS share price has gained 0.0%, excluding dividends.

What is Barinthus Biotherapeutics plc's 52-week range?

Over the last year Barinthus Biotherapeutics plc (BRNS) has traded between $0.51 and $2.91.

Related stock screens

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.